TNF Pharmaceuticals Inc. announced an amendment to its bylaws, effective May 9, 2025. The amendment modifies Article II, Section 2.09, changing the required stockholder vote for matters other than the election of directors. The new rule requires a majority of votes cast by stockholders present or represented by proxy, excluding abstentions and broker non-votes, for approval. This change also applies to class votes, where applicable.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TNF Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-009514), on May 09, 2025, and is solely responsible for the information contained therein.